Methotrexat Accord

Methotrexate, the active ingredient in Methotrexat Accord, is an antimetabolite presented as a sterile injectable solution for intraarterial, intramuscular, and intrathecal use. It is employed in the management of rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, osteosarcoma, and ectopic pregnancy, acting on rapidly dividing cells and immune pathways.

GNH USA supplies Methotrexat Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexate is an antimetabolite used in autoimmune, dermatologic and oncologic disease families.

- Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: limits skin cell proliferation and improves plaque lesions. - Acute lymphoblastic leukemia: interferes with malignant lymphoblast replication. - Osteosarcoma: hampers tumor growth by blocking DNA synthesis. - Ectopic pregnancy: terminates trophoblastic tissue when surgery is not feasible.

Methotrexate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea and vomiting. - Fatigue or malaise. - Oral ulcers or mucositis. - Elevated liver enzymes. - Low blood cell counts (anemia, leukopenia, thrombocytopenia). - Skin rash or photosensitivity.

Serious or Rare Side Effects: - Severe hepatotoxicity or fibrosis. - Pulmonary toxicity (interstitial pneumonitis). - Renal impairment or failure. - Life‑threatening infections due to immunosuppression. - Myelosuppression leading to severe pancytopenia. - Rare neurotoxicity when administered intrathecally.

Methotrexate requires careful monitoring and specific safety measures.

- Pregnancy: contraindicated (Category X); avoid use in pregnant or planning patients. - Renal function: assess creatinine clearance before initiation and periodically thereafter. - Hepatic health: perform baseline liver function tests and monitor during therapy. - Hematology: obtain complete blood count prior to treatment and at regular intervals. - Concomitant drugs: review for potential interactions that may increase toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Methotrexate interacts with several drug classes that can modify its efficacy or toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate serum levels and risk of toxicity. - Proton pump inhibitors (e.g., omeprazole): may reduce renal clearance, enhancing adverse effects. - Penicillins (e.g., ampicillin): can impair renal excretion, raising plasma concentrations.

Moderate Interactions (Monitor Closely): - Sulfonamides and trimethoprim: additive bone marrow suppression. - Azathioprine or other immunosuppressants: heightened risk of infection. - Vitamin supplements containing folic acid: may diminish therapeutic effect, requiring dose adjustment.